Skip to content

Drug interactions

Nirmatrelvir / ritonavir + Tenofovir alafenamide

Severity: Minor

Nirmatrelvir / ritonavir and Tenofovir alafenamide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ritonavir inhibits P-glycoprotein, increasing intestinal absorption of tenofovir alafenamide and raising tenofovir exposure. Boosted regimens are labeled for use with a reduced tenofovir alafenamide dose in some products, and short courses of nirmatrelvir/ritonavir are generally considered acceptable.

What this interaction means in plain words

Nirmatrelvir / ritonavir and Tenofovir alafenamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Moderate

Why it happens

Ritonavir inhibits intestinal P-gp efflux of tenofovir alafenamide, increasing its absorption.

What to do

No dose change is typically needed for the short 5-day course. Monitor renal function if used in patients with renal impairment.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nirmatrelvir / ritonavir and Tenofovir alafenamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Nirmatrelvir / ritonavir with Tenofovir alafenamide?

MediHelp rates the interaction as minor. Nirmatrelvir / ritonavir and Tenofovir alafenamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ritonavir inhibits P-glycoprotein, increasing intestinal absorption of tenofovir alafenamide and raising tenofovir exposure. Boosted regimens are labeled for use with a reduced tenofovir alafenamide dose in some products, and short courses of nirmatrelvir/ritonavir are generally considered acceptable.

How serious is the interaction between Nirmatrelvir / ritonavir and Tenofovir alafenamide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is typically needed for the short 5-day course. Monitor renal function if used in patients with renal impairment.

What other medicines interact with Tenofovir alafenamide?

MediHelp also lists interactions of Tenofovir alafenamide with, for example, Apalutamide, Berotralstat, Danicopan. The full list is on the Tenofovir alafenamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in